Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of probiotics, prebiotics, and synbiotics in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Lim Rong, Daniel Ch’ng, Pingping Jia, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 10, pp. 1682-1694
Open Access | Times Cited: 22

Showing 22 citing articles:

Surviving Sepsis Campaign Research Priorities 2023
Daniel De Backer, Clifford S. Deutschman, Judith Hellman, et al.
Critical Care Medicine (2024) Vol. 52, Iss. 2, pp. 268-296
Open Access | Times Cited: 42
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 19
Microencapsulation of Probiotics for Enhanced Stability and Health Benefits in Dairy Functional Foods: A Focus on Pasta Filata Cheese
Vita D’Amico, Michele Cavaliere, Marianna Ivone, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 185-185
Open Access | Times Cited: 2
The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: a systematic review and meta-analysis of randomized controlled trials
Vali Musazadeh, Kimia Assadian, Fatemeh Rajabi, et al.
Pharmacological Research (2024) Vol. 208, pp. 107398-107398
Open Access | Times Cited: 10
Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity
Jing Lu, Dilireba Shataer, Huizhen Yan, et al.
Foods (2024) Vol. 13, Iss. 18, pp. 2992-2992
Open Access | Times Cited: 9
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Anna Alisi, Geoffrey W. McCaughan, Henning Grønbæk
Hepatology International (2024) Vol. 18, Iss. S2, pp. 861-872
Closed Access | Times Cited: 8
The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis
Yijia Song, Sutong Liu, Lihui Zhang, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 1
Review of current and new drugs for the treatment of metabolic-associated fatty liver disease
Robert G. Gish, Jian‐Gao Fan, Zahra Dossaji, et al.
Hepatology International (2024)
Closed Access | Times Cited: 8
Probiotic supplementation for 24 weeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial
Amanda Souza Silva-Sperb, Helena Abadie Moraes, Samantha Thifani Alrutz Barcelos, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 7
Probiotic consumption and hepatic steatosis: results from the NHANES 2011–2016 and Mendelian randomization study
Yancheng Song, Wencong Guo, Junke Wang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 4
Gut microbiome in non-alcoholic fatty liver disease
Anastasios Mpountouridis, Christina Tsigalou, Ioanna Bezirtzoglou, et al.
Frontiers in Gastroenterology (2025) Vol. 3
Open Access
An umbrella review of meta-analyses on the effects of microbial therapy in metabolic dysfunction-associated steatotic liver disease
Yuanyue Yao, Qing Hong, Siqi Ding, et al.
Clinical Nutrition (2025) Vol. 47, pp. 1-13
Closed Access
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver disease
Sang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, et al.
The Journal of Microbiology (2025) Vol. 63, Iss. 2, pp. e2411002-e2411002
Closed Access
A negative correlation of low estimated glucose disposal rate with significant liver fibrosis in adults with NAFLD and obesity: results from NHANES 2017–2020
Xuecheng Tong, Kai Liu, Junying Xu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Recent advances in therapeutic probiotics: insights from human trials
Mu-Yeol Cho, Jeong-Sik Eom, Eun-Mi Choi, et al.
Clinical Microbiology Reviews (2025)
Closed Access
(Poly)phenol-gut microbiota interactions and their impact on human health
Xiaohe Liu, Amnah A. Alharbi, Rachel Gibson, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2025)
Closed Access
Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice
Kaikai Lu, Yimeng Zhou, Lei He, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 6
Closed Access | Times Cited: 3
Characterization of gut dysbiosis and intestinal barrier dysfunction in patients with metabolic dysfunction-associated steatotic liver disease and chronic kidney disease: a comparative study
Thasinas Dissayabutra, Natthaya Chuaypen, Pornjira Somnark, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Probiotics Supplementation during Pregnancy: Can They Exert Potential Beneficial Effects against Adverse Pregnancy Outcomes beyond Gestational Diabetes Mellitus?
Efthymios Poulios, Eleni Pavlidou, Sousana Κ. Papadopoulou, et al.
Biology (2024) Vol. 13, Iss. 3, pp. 158-158
Open Access | Times Cited: 2
The role of the gut-liver axis in modulating non-alcoholic fatty liver disease through dietary patterns and microecological agents
Yucheng Fang, Ziyang Fang, Ziwei Li, et al.
Food Bioscience (2023) Vol. 56, pp. 103335-103335
Closed Access | Times Cited: 5
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Sunitha Vimalesvaran, Pietro Vajro, Anil Dhawan
Hepatology International (2024)
Open Access | Times Cited: 1
Lactitol properties in the treatment of patients with lifestyle-related diseases
M. V. Maevskaya, С. В. Оковитый
Meditsinskiy sovet = Medical Council (2024), Iss. 8, pp. 162-169
Open Access
The impact of perioperative synbiotics treatment in living-donor liver transplantation after induction of early enteral nutrition
Shohei Yoshiya, Shinji Itoh, Takeo Toshima, et al.
Surgery Today (2024)
Closed Access
Meta-analysis of randomized controlled trials of the effects of synbiotics, probiotics, or prebiotics in controlling glucose homeostasis in non-alcoholic fatty liver disease patients
Siqi Ding, Qing Hong, Yuanyue Yao, et al.
Food & Function (2024) Vol. 15, Iss. 19, pp. 9954-9971
Closed Access
Page 1

Scroll to top